Verrica Pharmaceuticals Inc.

NASDAQ:VRCA

1.94 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016
Operating Activities:
Net Income -66.995-24.487-35.08-42.694-28.207-20.648-4.459-1.913
Depreciation & Amortization 0.8360.7180.4720.2290.2570.0200
Deferred Income Tax 1.65900.066-0.1380000
Stock Based Compensation 14.3764.9856.0539.8213.3332.2510.0820.009
Change In Working Capital 9.859-1.8-0.5351.635-1.7280.938-0.2060.293
Accounts Receivables -3.929-0.487000000
Inventory 00.487000000
Accounts Payables 2.201-0.3380.497-0.8380.2250.7930.0640.071
Other Working Capital 11.587-1.462-1.0322.473-1.9530.145-0.270.222
Other Non Cash Items 1.6881.9341.4420.94-1.063-0.4350.018-0.062
Operating Cash Flow -38.577-18.65-27.582-30.207-27.408-17.874-4.583-1.611
Investing Activities:
Investments In Property Plant And Equipment -0.362-0.302-0.883-1.47-0.682-0.77400
Acquisitions Net 00000000
Purchases Of Investments 0-4.485-68.914-71.738-89.854-79.1200
Sales Maturities Of Investments 059.0086969.849117.715000
Other Investing Activites 0-0.18-0.201-0.221-1.224-0.49900
Investing Cash Flow -0.36254.041-0.998-3.5825.955-79.89400
Financing Activities:
Debt Repayment -44.105-43.754-0.005-34.162-0.119000
Common Stock Issued 30.1326.90128.1180.4530.42386.2512.7190.483
Common Stock Repurchased 00000000
Dividends Paid 00000000
Other Financing Activities 88.188-0.0175.53368.9410.11913.12612.7190.483
Financing Cash Flow 74.213-16.8733.64635.2320.42399.37612.7190.483
Other Information:
Effect Of Forex Changes On Cash 00000000
Net Change In Cash 35.27418.5215.0661.445-1.031.6088.136-1.128
Cash At End Of Period 69.54734.27315.75210.6869.24110.2718.6630.527